Good article Baldy, RECCE 327 is well advanced compared to other biotech's and RECCE 327 is a much more broad spectrum Superbug antibiotic however the other good thing is that the US$1 Billion on offer from the CARB-X Global Initiative is for each new antibiotic approved, not just the first one.
.
.
Accelerated Approval for RECCE® 327, page-25
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
-0.005(1.08%) |
Mkt cap ! $100.9M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 46.5¢ | 45.5¢ | $182.0K | 395.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 112713 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 148015 | 6 |
View Market Depth
| Last trade - 14.07pm 11/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |